Journal of Internal Medicine Concepts & Practice ›› 2023, Vol. 18 ›› Issue (03): 157-164.doi: 10.16138/j.1673-6087.2023.03.005
• Original article • Previous Articles Next Articles
LI Hua1,2*, HUANG Xiaomin1*, ZHANG Chunyan1, DU Lu1,3, REN Hong1, XU Tian1()
Received:
2022-11-07
Online:
2023-06-30
Published:
2023-08-07
CLC Number:
LI Hua, HUANG Xiaomin, ZHANG Chunyan, DU Lu, REN Hong, XU Tian. Value of serum N-terminal pro-brain natriuretic peptide levels in primary screening peritoneal dialysis patients with volume overload[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(03): 157-164.
指标 | 容量正常组(n=59) | 容量超负荷组(n=52) | 统计量 | P |
---|---|---|---|---|
年龄(岁) | 55.99±14.75 | 53.91±14.57 | 0.155 | >0.05 |
性别(男/女) | 29/31 | 34/18 | 2.967 | >0.05 |
BMI(kg/m2) | 22.53±2.84 | 22.39±3.38 | 2.010 | >0.05 |
收缩压(mmHg) | 140.00±20.64 | 152.50±24.12 | 0.283 | 0.004 |
舒张压(mmHg) | 82.75±11.72 | 86.54±13.46 | 0.608 | >0.05 |
透析龄(月) | 62.3(46.5,81.2) | 65.8(42.8,92.5) | 3 134.0 | >0.05 |
透析剂量(L/24 h) | 7.84±1.80 | 8.46±1.75 | 0.391 | >0.05 |
尿量(mL/24 h) | 800(220,1 200) | 300(0,748) | 2 373.5 | 0.001 |
超滤量(mL/24 h) | 500(225,760) | 665(325,975) | 2 979.0 | >0.05 |
Kt/V | 2.24±0.42 | 2.04±0.49 | 2.588 | 0.024 |
CCr(L/周) | 70.75±25.99 | 58.72±19.22 | 7.145 | 0.007 |
nPCR | 0.94±0.16 | 0.92±0.21 | 1.910 | >0.05 |
4hD/PCr(μmol/L) | 0.59±0.09 | 0.65±0.11 | 4.685 | 0.003 |
腹膜转运类型(低/高) | 44/15 | 24/28 | 9.409 | 0.002 |
降压药种类(<3种及≥3种) | 46/13 | 22/29 | 14.058 | 0.000 |
利尿剂种类(有/无) | 54/5 | 32/19 | 13.283 | 0.000 |
CRP(mg/L) | 1.55(0.52,4.63) | 1.87(0.65,5.81) | 3 129.5 | >0.05 |
血红蛋白(g/L) | 112.22±16.07 | 105.25±17.27 | 0.555 | 0.030 |
血钠(mmol/L) | 141.28±2.86 | 140.92±2.75 | 0.348 | >0.05 |
血糖(mmol/L) | 5.25±1.78 | 4.98±1.13 | 1.370 | >0.05 |
血清白蛋白(mmol/L) | 36.71±4.34 | 33.81±4.83 | 0.535 | 0.001 |
血钙(mmol/L) | 2.34±0.16 | 2.28±0.17 | 0.632 | >0.05 |
血磷(mmol/L) | 1.69±0.45 | 1.73±0.53 | 1.749 | >0.05 |
总胆固醇(mmol/L) | 5.09±1.07 | 4.77±1.29 | 1.966 | >0.05 |
甘油三酯(mmol/L) | 2.02±1.10 | 1.71±1.12 | 0.016 | >0.05 |
低密度脂蛋白(mmol/L) | 3.11±0.93 | 2.90±1.04 | 0.820 | >0.05 |
Iog 2(NT-proBNP) | 10.93±2.22 | 12.60±1.95 | 1.171 | 0.000 |
指标 | 容量正常组(n=59) | 容量超负荷组(n=52) | 统计量 | P |
---|---|---|---|---|
IVST(mm) | 9.90±1.50 | 11.04±2.10 | 1.375 | 0.002 |
LVPWT(mm) | 9.65±1.57 | 10.51±2.43 | 2.408 | 0.037 |
LAD(mm) | 38.50±5.20 | 41.12±4.68 | 0.455 | 0.009 |
LVESD(mm) | 32.42±5.40 | 32.57±4.63 | 0.334 | >0.05 |
LVEDD(mm) | 50.39±5.56 | 51.31±4.98 | 1.458 | >0.05 |
LVESV(mL) | 44.50±20.12 | 44.33±15.93 | 0.354 | >0.05 |
LVEDV(mL) | 122.56±32.64 | 128.10±29.53 | 1.126 | >0.05 |
LVEF(%) | 64.65±6.69 | 65.82±5.03 | 0.546 | >0.05 |
OH(L) | 1.4(0.8,2.3) | 3.9(3.2,5.28) | 1 847.0 | 0.000 |
TBW(L) | 34.30±7.03 | 38.28±9.94 | 3.437 | 0.016 |
ECW(L) | 15.65±2.90 | 18.78±4.83 | 5.361 | 0.000 |
ICW(L) | 18.65±4.34 | 19.50±5.46 | 1.599 | >0.05 |
OH/TBW | 0.46(0.24,0.62) | 0.11(0.84,0.14) | 1 778.0 | 0.000 |
ECW/TBW | 0.460±0.027 | 0.493±0.029 | 0.347 | 0.000 |
ECW/ICW | 0.855±0.092 | 0.978±0.116 | 2.363 | 0.000 |
指标 | r | P |
---|---|---|
收缩压 | 0.320 | 0.001 |
透析龄 | 0.301 | 0.001 |
超滤量 | 0.435 | 0.000 |
透析剂量 | 0.469 | 0.000 |
降压药分组 | 0.404 | 0.000 |
IVST | 0.534 | 0.000 |
LVPWT | 0.543 | 0.000 |
LAD | 0.547 | 0.000 |
LVESD | 0.346 | 0.000 |
LVEDD | 0.357 | 0.000 |
OH | 0.496 | 0.000 |
OH/ECW | 0.516 | 0.000 |
尿量 | -0.589 | 0.000 |
总Kt/V | -0.352 | 0.000 |
总CCr | -0.538 | 0.000 |
nPCR | -0.192 | 0.043 |
血红蛋白 | -0.382 | 0.000 |
血清白蛋白 | -0.228 | 0.016 |
LVEF | -0.213 | 0.032 |
指标 | NT-proBNP≥4 896 ng/L(n=48) | NT-proBNP<4 896 ng/L(n=63) | 统计量 | P |
---|---|---|---|---|
BMI(kg/m2) | 22.85±2.91 | 22.15±3.23 | 0.227 | >0.05 |
收缩压(mmHg) | 152.40±25.06 | 140.29±19.95 | 2.032 | 0.005 |
尿量(mL/24 h) | 135.0(0,437.5) | 800(500,1 200) | 1 792.5 | 0.000 |
超滤量(mL/24 h) | 767.0(500.0,1 022.5) | 480(224,698) | 2 896.0 | 0.000 |
Kt/V | 1.97±0.38 | 2.28±0.47 | 1.033 | 0.000 |
CCr(L/周) | 51.7(45.8,56.9) | 69.3(52.8,90.3) | 1 886.0 | 0.000 |
IVST(mm) | 11.47±2.07 | 9.71±1.34 | 2 261.5 | 0.000 |
LVPWT(mm) | 11.16±2.49 | 9.26±1.18 | 2 248 | 0.000 |
LVEF(%) | 63.84±7.48 | 66.24±7.48 | 1 996.5 | 0.044 |
OH/ECW | 0.21±0.10 | 0.12±0.07 | 5.593 | 0.000 |
[4] | Mair J. Biochemistry of B-type natriuretic peptide—where are we now?[J]. Clin Chem Lab Med, 2008, 46(11): 1507-1514. |
[5] |
Breidthardt T, Kalbermatter S, Socrates T, et al. Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients[J]. Eur J Heart Fail, 2011, 13: 860-867.
doi: 10.1093/eurjhf/hfr057 pmid: 21628312 |
[6] |
Winkler K, Wanner C, Drechsler C, et al. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients[J]. Eur Heart J, 2008, 29: 2092-2099.
doi: 10.1093/eurheartj/ehn278 pmid: 18617483 |
[7] |
Gutiérrez OM, Tamez H, Bhan I, et al. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements[J]. Clin Chem, 2008, 54(8): 1339-1348.
doi: 10.1373/clinchem.2007.101691 pmid: 18539645 |
[8] |
Paniagua R, Amato D, Mujais S, et al. Predictive value of brain natriuretic peptides in patients on peritoneal dialysis[J]. Clin J Am Soc Nephrol, 2008, 3(2): 407-415.
doi: 10.2215/CJN.03820907 URL |
[9] |
Plum J, Schoenicke G, Kleophas W, et al. Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods[J]. Nephrol Dial Transplant, 2001, 16(12):2378-2385.
doi: 10.1093/ndt/16.12.2378 URL |
[10] | van den Wall Bake AW, Kooman JP, Lange JM, et al. Adequacy of peritoneal dialysis and the importance of preserving residual renal function[J]. Nephrol Dial Transplant, 2006, 21 Suppl 2: ii34-ii37. |
[11] |
Cheng LT, Chen W, Tang W, et al. Residual renal function and volume control in peritoneal dialysis patients[J]. Nephron Clin Pract, 2006, 104(1): c47-c54.
doi: 10.1159/000093670 URL |
[12] |
Devolder I, Verleysen A, Vijt D, et al. Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients[J]. Perit Dial Int, 2010, 30(2): 208-214.
doi: 10.3747/pdi.2008.00284 URL |
[13] |
Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients[J]. Nephrol Dial Transplant, 2009, 24(5): 1574-1579.
doi: 10.1093/ndt/gfn707 URL |
[14] |
Passauer J, Petrov H, Schleser A, et al. Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy[J]. Nephrol Dial Transplant, 2010, 25(2): 545-551.
doi: 10.1093/ndt/gfp517 URL |
[15] |
Lopot F, Nejedly B, Novotná H, et al. Age-related extracellular to total body water volume ratio (Ecv/TBW)—can it be used for "dry weight" determination in dialysis patients?[J]. Int J Artif Organs, 2002, 25(8): 762-769.
pmid: 12296460 |
[16] |
Yilmaz Z, Yildirim Y, Oto F, et al. Evaluation of volume overload by bioelectrical impedance analysis, NT-proBNP and inferior vena cava diameter in patients with stage 3&4 and 5 chronic kidney disease[J]. Ren Fail, 2014, 36(4): 495-501.
doi: 10.3109/0886022X.2013.875815 URL |
[17] |
Park WY, Park S, Kim YW, et al. Clinical efficacy of biomarkers for evaluation of volume status in dialysis patients[J]. Medicine (Baltimore), 2020, 99(31): e21460.
doi: 10.1097/MD.0000000000021460 URL |
[18] |
Vickery S, Price CP, John RI, et al. B-type natriuretic peptide(BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy[J]. Am J Kidney Dis, 2005, 46(4): 610-620.
doi: 10.1053/j.ajkd.2005.06.017 pmid: 16183415 |
[19] |
Palmer SC, Yandle TG, Nicholls MG, et al. Regional clearance of amino-terminal pro-brain natriuretic peptide from human plasma[J]. Eur J Heart Fail, 2009, 11(9): 832-839.
doi: 10.1093/eurjhf/hfp099 pmid: 19605456 |
[20] |
Jacobs LH, van de Kerkhof JJ, Mingels AM, et al. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study[J]. Nephrol Dial Transplant, 2010, 25(1): 243-248.
doi: 10.1093/ndt/gfp417 URL |
[21] |
Booth J, Pinney J, Davenport A. N-terminal proBNP—marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?[J]. Clin J Am Soc Nephrol, 2010, 5(6): 1036-1040.
doi: 10.2215/CJN.09001209 URL |
[22] | Ridao N, Luño J, García de Vinuesa S, et al. Prevalence of hypertension in renal disease[J]. Nephrol Dial Transplant, 2001, 16 Suppl 1: 70-73. |
[23] | Alvarez-Lara MA, Martín-Malo A, Espinosa M, et al. Blood pressure and body water distribution in chronic renal failure patients[J]. Nephrol Dial Transplant, 2001, 16 Suppl 1: 94-97. |
[24] |
Celik G, Kara I, Yilmaz M, et al. The relationship between bioimpedance analysis, haemodynamic parameters of haemodialysis, biochemical parameters and dry weight[J]. J Int Med Res, 2011, 39(6): 2421-2428.
pmid: 22289562 |
[25] |
Jang M, Kim WH, Lee JH, et al. Numerical expression of volume status using the bioimpedance ratio in continuous ambulatory peritoneal dialysis patients[J]. Kidney Res Clin Pract, 2017, 36(3): 290-295.
doi: 10.23876/j.krcp.2017.36.3.290 pmid: 28904881 |
[26] |
Flythe JE, Chang TI, Gallagher MP, et al. Blood pressure and volume management in dialysis[J]. Kidney Int, 2020, 97(5): 861-876.
doi: 10.1016/j.kint.2020.01.046 URL |
[27] |
DeFilippi C, van Kimmenade RR, Pinto YM. Amino-terminal pro-B-type natriuretic peptide testing in renal disease[J]. Am J Cardiol, 2008, 101(3A): 82-88.
doi: 10.1016/j.amjcard.2007.11.029 pmid: 18243865 |
[1] |
Zoccali C, Moissl U, Chazot C, et al. Chronic fluid overload and mortality in ESRD[J]. J Am Soc Nephrol, 2017, 28: 2491-2497.
doi: 10.1681/ASN.2016121341 pmid: 28473637 |
[2] |
Wang AY, Brimble KS, Brunier G, et al. ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part Ⅰ-assessment and management of various cardiovascular risk factors[J]. Perit Dial Int, 2015, 35: 379-387.
doi: 10.3747/pdi.2014.00279 URL |
[3] |
Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients[J]. Nephrol Dial Transplant, 2009, 24(5): 1574-1579.
doi: 10.1093/ndt/gfn707 URL |
[28] |
Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients[J]. J Am Soc Nephrol, 2001, 12(7): 1508-1515.
doi: 10.1681/ASN.V1271508 pmid: 11423580 |
[1] | WANG Chaojun, YU Ling, WANG Hengjie, REN Hong, SHI Manman, ZHENG Hong, MA Yuhua, XU Tian. Contrast study on efficacy of ultrasound-guided transversus abdominis plane block combined with rectus sheath block in peritoneal dialysis catheterization [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(03): 152-156. |
[2] | LU Wei, LI Xuting, YU Weibin, XIA Yimeng, FAN Qiuwei. Continuous cardiac index in patients related with left ventricular ejection fraction in preanesthesia assessment for gastroenteroscopy [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 152-156. |
[3] | HUANG Xiaomin, ZHANG Qianying, YANG Li, CUI Yan, XU Tian, WANG Ziqiu, WANG Zhaohui, REN Hong, ZHANG Chunyan. A cross-sectional study of falls in peritoneal dialysis patients [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 248-252. |
[4] | GUI Yanping, CHEN Yefen, SHI Zhongwei, XU Yan. Study on use of right ventricular fractional area change assessed by echocardiogram for evaluating cardiac synchrony in heart failure patients with reduced left ventricular ejection fraction [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 331-335. |
[5] | WANG Chenchen, FANG Yuehua, SHI Zhongwei, QU Xuezheng. Effect of surgical aortic valvuloplasty for aortic insufficiency using echocardiography one year after surgery in 25 patients [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 395-398. |
[6] | CHEN Tao, XU Yu, FU Xueliang, YUAN Zhiqing, HUA Rong. Surgical treatment for inguinal hernia in continuous ambulatory peritoneal dialysis patients [J]. Journal of Surgery Concepts & Practice, 2021, 26(5): 425-429. |
[7] | LUO Xiaoying, XU Yan, ZHANG Jiansheng, WU Liqun, QI Wenhang. Predictive value of NT-proBNP for new-onset atrial fibrillation following acute myocardial infarction [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 303-307. |
[8] | WANG Chenchen, YANG Wenbo, HUA Wei, CHEN Yefen, SU Xiuxiu, GONG Junshi, FANG Yuehua. The morphology and function of left atrial appendage in the risk assessment of stroke in patients with non-valvular atrial fibrillation [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 151-156. |
[9] | XU Tingyan, YANG Yan, LI Jingjing, ZHANG Dongyan, WANG Ying, WANG Jiguang, LI Yan. Association between 24-h ambulatory blood pressure variability and cardiac structure and function [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 193-198. |
[10] | . [J]. Journal of Internal Medicine Concepts & Practice, 2018, 13(04): 227-230. |
[11] | . [J]. Journal of Internal Medicine Concepts & Practice, 2018, 13(03): 165-169. |
[12] | CHEN Yefen, SHI Zhongwei. Evaluation of ventricular systolic function and left ventricular synchrony in patients with dilated cardiomyopathy using single beat real-time three-dimensional echocardiography [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(03): 292-296. |
[13] | . [J]. Journal of Internal Medicine Concepts & Practice, 2016, 11(04): 230-233. |
[14] | . [J]. Journal of Diagnostics Concepts & Practice, 2016, 15(03): 244-247. |
[15] | . [J]. Journal of Diagnostics Concepts & Practice, 2016, 15(03): 248-252. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||